News

According to a recent data study by the Institute for Public Policy Research, the UK's share of worldwide research and development (R&D) spending has decreased by 5% since 2014. Despite exceeding the government's aim of 2.4% GDP for R&D expenditure,...

Gene therapy remains a topic of fascination to biopharmaceutical dealmakers despite safety worries and opposition from drug regulators, as seen by a recent flurry of deals. Eli Lilly agreed to purchase Akouos, a Boston-based company that develops gene therapies for...

One of the most difficult medical research findings, drug distribution still faces a lot of challenges, including surviving the acidic parts of the stomach, digestive enzymes, and most significantly, the mucus barrier that surrounds the digestive canal. Scientists at...

Rising energy prices in Europe run the risk of accelerating the migration of businesses necessary for the production of life-saving medications, further jeopardising the pharma supply chains that were already struggling under the worst of COVID-19. Essential medications are important...

In 2021, the market for third-party logistics for the biopharmaceutical industry was estimated to be worth USD 117.25 billion. By 2030, it is expected to have grown to USD 195.75 billion, with a CAGR of 5.86% from 2022 to...

Your health comes first. Consequently, you don't mind spending more to buy all the supplements your doctor recommended. But you might face a financial crisis soon if you're not careful about the amount you've allocated to supplements. It's even worse...

The healthcare industry is undergoing a massive transformation. According to Statista, it's an industry that grew at a rate of 15.9% within five years from 2016, projected to reach USD$59.70 billion in 2022. Sure, the influence of technology is...